Who is sponsoring NCT03147170?

NCT03147170 is sponsored by University of Minnesota.

What drugs are being tested in NCT03147170?

Interventions in NCT03147170: High and low salt diets.

What condition does NCT03147170 study?

NCT03147170 studies Hypertension Uncomplicated, Pre Hypertension.

Is NCT03147170 still recruiting?

NCT03147170 is currently completed. Last updated 18 April 2019.

Last reviewed 2019-04-18 · How we verify

NCT03147170

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Biomarker to Detect Salt Sensitivity

Completed Last updated 18 April 2019

What this trial tests

trial testing High and low salt diets in Hypertension Uncomplicated in 30 participants. Completed in 31 December 2018.

Timeline

1 January 2016

Primary endpoint
30 June 2018

31 December 2018

Quick facts

Lead sponsor	University of Minnesota
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 January 2016
Primary completion	30 June 2018
Estimated completion	31 December 2018
Sites	1 location across United States

Drugs / interventions tested

High and low salt diets

Conditions studied

Hypertension Uncomplicated — all drugs for Hypertension Uncomplicated →
Pre Hypertension — all drugs for Pre Hypertension →

Sponsor

University of Minnesota

Who can join

Adults 30 to 75, any sex, with Hypertension Uncomplicated or Pre Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are proposing that individuals with elevated levels of NT-proBNP are resistant to natriuretic peptides and are unable to handle sodium loads and maintain optimal blood pressure values.The investigators will test this hypothesis by comparing the blood pressure response to low and high salt diets in individuals with pre- or hypertension and who have normal or elevated levels of NT-proBNP. The investigators expect that blood pressure values in those with normal levels of NT-proBNP will not change with high salt diets, whereas, in those with elevated levels of NT-proBNP, blood pressure values will increase significantly when exposed to high salt diets.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03147170 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 18 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03147170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing